Key Drivers of Biotechnology Valuation
A deep understanding of the key biotechnology valuation drivers is critical for those who have an interest in biotech assets and businesses- read how to conduct pharma and biotech valuation…
Optimal Strategy for Pharmaceutical Asset Commercialization
A Value-Driven Commercialization Strategy for Pharmaceutical Assets An optimal commercialization strategy for pharmaceutical and biotechnology companies is vital for the value maximization of the company. Early-stage, as well as developed…
Key To Success in Medical Devices Competitive Intelligence
Effective Competitive Intelligence Strategies for Gaining an Edge in the Medical Devices Industry Medical devices are an important part of the healthcare industry, with tremendous potential to improve patient outcomes…
Critical Success Factors in Pharmaceutical Due Diligence
Key Success Factors for Effective Pharmaceutical Due Diligence and Risk Mitigation Due diligence is defined as the process by which buyers conduct the evaluation of investment opportunities. Several factors are…
Pharmaceutical Path-to-Market Competitive Intelligence for Competitive Advantage
Leveraging Path-to-Market Competitive Intelligence for Pharma Commercialization and Competitive Advantage Pharmaceutical Path-to-Market Competitive Intelligence is insights collection and generation across an asset's journey towards markets. Competitive Intelligence (CI) is a…
Optimally Leveraging Biosimilars Competitive Intelligence in the Pharma Industry
How to Effectively Utilize Biosimilars Competitive Intelligence for Pharma Industry Success Are companies leveraging biosimilars competitive intelligence maximally? A myriad of economic and patients’ benefits arguments could be made for…
Social Media for Competitive Intelligence in the Pharmaceutical Sector
Leveraging Social Media for Competitive Intelligence in the Pharmaceutical Industry Here we describe a guide to leveraging 'Social Media for Competitive Intelligence in the Pharmaceutical Sector'. Like that of any…